Complaint·March 4, 2024

CONTINUED FROM FORM LIC9099 Regarding the allegation that Staff mishandled a resident's medication while in care , the following has been concluded: Interviews and review of records confirmed that resident R1 was unable to receive the medication Tolvaptan as prescribed by their primary care physician on one instance on February 24, 2024 after the facility exhausted their current supply of the medication. However, interviews with facility staff evidenced that the medication had been identified to require a refill as early as February 5, 2024. Facility medication staff reached out to the pharmacy in charge of filling the medication orders for R1 at that time and were informed that the refill was pending approval from the resident's health insurance provider. Per the medication staff communication log, additional follow-up calls were placed on February 7, February 12, February 20 and February 24 as well as on February 27, 2024. There are documented instances of such pre-approvals being granted by insurance in the past, however in that instance the pre-authorization was alleged declined and is currently pending appeal to the insurance provider. In the meantime, due to the reported prohibitive cost of the medication, R1 has been provided with samples provided by the primary care provider in order to maintain the prescribed dispensation schedule and avoid any adverse effects. A review of the medication administration records and multiple interviews confirmed that R1 has since been receiving every dose as prescribed. Based on the evidence gathered, it cannot be determined that the missed medication dose was the result of a negligence from facility staff, therefore the allegation is found to be Unsubstantiated, meaning that although the allegation may have happened or is valid, there is not a preponderance of evidence to prove or refute the alleged violation occurred. An exit interview was conducted and a copy of this report was provided to a facility representative.